iCardiac Overview
- Founded
- 2006
- Status
- Acquired/Merged
- Employees
- 200
- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 7
- Investments
- 1
iCardiac General Information
Description
Provider of cardiac safety and respiratory services intended to help drug development program run more efficiently. The company's on-demand expertise for cardiac safety and respiratory services include High Precision QT and Early Precision QT methodologies that sets a new standard for precision and accuracy in all phases of human drug trials, to ensure that subjects are not inappropriately included or excluded from studies, enabling small and mid-sized pharma and biotech companies to advance in the field of cardiac safety.
Contact Information
Primary Industry
Other Healthcare Services
Other Industries
Consulting Services (B2B)
Acquirer
Primary Office
- 150 Allens Creek
- Rochester, NY 14618
- United States
+1 (585) 000-0000
iCardiac Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore iCardiac‘s full profile, request access.
Request a free trialiCardiac Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of cardiac safety and respiratory services intended to help drug development program run more efficiently. The
Other Healthcare Services
Rochester, NY
200
As of 2017
00.00
000000000000
00.00
0000000
empor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitatio
0000000000 00000000 (000)
Bethesda, MD
000
As of 0000
000000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialiCardiac Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 0000000 | Formerly PE-Backed | Bethesda, MD | 000 | 000000000000 |
iCardiac Patents
iCardiac Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130096447-A1 | System and methods for serial analysis of electrocardiograms | Abandoned | 27-Sep-2011 | 000000000 | 00 |
| US-20110184296-A1 | Method and system for quantitative assessment of cardiac electrical events | Abandoned | 27-Jan-2010 | 000000000 | 0 |
| US-20110112414-A1 | System for automated ekg analysis | Abandoned | 06-Nov-2009 | 000000000 | 0 |
| US-20110105928-A1 | Ecg reconstruction for atrial activity monitoring and detection | Abandoned | 05-Nov-2009 | 0000000000 | 00 |
| US-20100317985-A1 | System for quantitative assessment of cardiac electrical events | Abandoned | 12-Jun-2009 | A61B5/316 | 0 |
iCardiac Executive Team (16)
iCardiac Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0. 000000 000000000 | Self | Co-Founder, Chief Innovation Officer and Board Member | 000 0000 |
iCardiac Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialiCardiac Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore iCardiac‘s full profile, request access.
Request a free trialiCardiac Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000 | 06-Aug-2015 | 0000000000 | Other Healthcare Services | 000000000 |